Skip to main content
. 2021 Dec 13;11(10):e12086. doi: 10.1002/clt2.12086

TABLE 1.

Classificasion of chemotherapeutic agents based on risk to induce hypersensitivity reactions 7

Drugs with high potential Drugs with intermediate potential Drugs with low potential
Platinum compounds Anthracyclines Cytarabine
Oxaliplatin Doxorubicin Cyclophosphamide
Carboplatin Daunorubicin Ifosfamide
Cisplatin Epirubicin
Taxanes Idarubicin
Paclitaxel 6‐Mercaptopurine
Docetaxel Azathioprine
Other cytostatic drugs Methotrexate
L‐Asparaginase
Procarbazine
Epipodophyllotoxins
Teniposide
Etoposide